CASI Pharmaceuticals, Inc.
- Biotech or pharma, therapeutic R&D
CASI US is an innovative biopharmaceutical company developing a potentially best-in-class anti-CD38 monoclonal for various autoimmune diseases and organ transplant rejection. CASI China is focused on the development and commercialization of innovative therapeutics for hematology/oncology and autoimmune diseases.
Address
South San FranciscoCalifornia
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}